Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Luminex Corporation    LMNX

Delayed Quote. Delayed  - 06/29 09:59:58 pm
19.89 USD   +3.54%
06/22 LUMINEX : Announces Commencement of Tender Offer for All Outstanding..
06/22 LUMINEX CORPORA : To Present At Cantor Fitzgerald's 2nd Annual Healt..
06/21 NANOSPHERE : Announces Intent to Voluntarily Delist From NASDAQ Capi..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/23/2016 06/24/2016 06/27/2016 06/28/2016 06/29/2016 Date
20(c) 19.51(c) 18.99(c) 19.21(c) 19.91(c) Last
126 630 719 337 242 240 278 299 231 347 Volume
+1.57% -2.45% -2.67% +1.16% +3.64% Change
More quotes
Financials ($)
Sales 2016 251 M
EBIT 2016 39,1 M
Net income 2016 31,6 M
Debt 2016 -
Yield 2016 -
Sales 2017 265 M
EBIT 2017 47,5 M
Net income 2017 33,5 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 30,25
P/E ratio 2017 26,68
Capi. / Sales2016 3,31x
Capi. / Sales2017 3,14x
Capitalization 833 M
More Financials
Company
Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries.Luminex was founded by Mark B. Chandler and Van S. Chandler in May 1995 and is headquartered in Austin, TX. 
Sector
Advanced Medical Equipment & Technology
Calendar
07/13 | 09:30pmPresentation
More about the company
Surperformance© ratings of Luminex Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on LUMINEX CORPORATION
06/22 LUMINEX : Announces Commencement of Tender Offer for All Outstanding Shares of N..
06/22 LUMINEX CORPORATION : To Present At Cantor Fitzgerald's 2nd Annual Healthcare Co..
06/21 NANOSPHERE : Announces Intent to Voluntarily Delist From NASDAQ Capital Market
06/09 LUMINEX CORPORATION : Receives CE-IVD Mark for ARIES Flu A/B & RSV Assay
06/09 LUMINEX CORPORATION : Announces Commencement of Tender Offer for All Outstanding..
06/02 LUMINEX : "Instrument for Cassette for Sample Preparation" in Patent Application..
06/02 LUMINEX : Receives CE-IVD Mark for ARIES Flu A/B & RSV Assay
06/01 LUMINEX : To Present At Jefferies 2016 Healthcare Conference
05/26 LUMINEX : and Nanosphere, Inc. Provide Update on Acquisition Agreement
05/26 LUMINEX CORPORATION : To Present At Jefferies 2016 Healthcare Conference
More news
Sector news : Advanced Medical Equipment & Technology - NEC
06/29 SARTORIUS : IntelliCyt bought by Germany’s Sartorius for $90M
06/29 RESMED : Awarded Group Purchasing Contract with Premier
06/29 OLYMPUS : Ruling ordering Olympus to pay damages over loss coverup upheld
06/29 AGILENT TECHNOLOGIES : to Acquire Assets from iLab Solutions
06/28 HOLOGIC : FDA Grants Emergency Use Authorization for Zika Virus Assay
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
05/24 P&G&C&D? Will P&G Pay A 70% Premium For C&D? (Probably Not)
05/19 Amazon Is A Criminal Monopoly? Donald Trump Says So
05/16 Luminex buys Nanosphere for $58M
05/02 Luminex's (LMNX) CEO Homi Shamir on Q1 2016 Results - Earnings Call Transcrip..
05/02 Luminex beats by $0.15, beats on revenue
Advertisement
Chart LUMINEX CORPORATION
Duration : Period :
Luminex Corporation Technical Analysis Chart | LMNX | US55027E1029 | 4-Traders
Full-screen chart
Technical analysis trends LUMINEX CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions